China's CSPC Pharmaceutical Group Limited said on Wednesday its messenger RNA (mRNA) COVID-19 vaccine has received emergency use authorisation from Chinese...
BEIJING (Reuters) - health authorities. The approval from the National Medical Products Administration means CSPC is the first company cleared to provide an mRNA vaccine in China - but it comes as COVID cases decline across the country after a recent surge. China has declined to use mRNA vaccines from abroad and vaccines available in China are widely considered less effective than the Moderna and Pfizer-BioNTech…